Cargando…
VEGF(121)-Conjugated Mesoporous Silica Nanoparticle: A Tumor Targeted Drug Delivery System
[Image: see text] The vascular endothelial growth factor (VEGF)/VEGF receptor (VEGFR) signaling cascade plays a critical role in tumor angiogenesis and metastasis and has been correlated with several poorly prognostic cancers such as malignant gliomas. Although a number of anti-VEGFR therapies have...
Autores principales: | Goel, Shreya, Chen, Feng, Hong, Hao, Valdovinos, Hector F., Hernandez, Reinier, Shi, Sixiang, Barnhart, Todd E., Cai, Weibo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4262629/ https://www.ncbi.nlm.nih.gov/pubmed/25353068 http://dx.doi.org/10.1021/am506849p |
Ejemplares similares
-
Engineering of Hollow Mesoporous Silica Nanoparticles for Remarkably Enhanced Tumor Active Targeting Efficacy
por: Chen, Feng, et al.
Publicado: (2014) -
In Vivo Integrity and Biological Fate of Chelator-Free Zirconium-89-Labeled Mesoporous Silica Nanoparticles
por: Chen, Feng, et al.
Publicado: (2015) -
In Vivo Tumor Vasculature Targeted PET/NIRF Imaging
with TRC105(Fab)-Conjugated, Dual-Labeled Mesoporous Silica Nanoparticles
por: Chen, Feng, et al.
Publicado: (2014) -
Engineering Intrinsically Zirconium‐89 Radiolabeled Self‐Destructing Mesoporous Silica Nanostructures for In Vivo Biodistribution and Tumor Targeting Studies
por: Goel, Shreya, et al.
Publicado: (2016) -
Chelator-Free Labeling of Layered Double Hydroxide Nanoparticles for in Vivo PET Imaging
por: Shi, Sixiang, et al.
Publicado: (2015)